Comment_老虎社区_美港股上老虎

2021-11-17

Comment

FDA promises quick review of Pfizer booster for all adults, CDC meets Friday<blockquote>FDA 承诺对所有成年人快速审查辉瑞加强剂，疾病预防控制中心周五召开会议</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":871428443,"tweetId":"871428443","gmtCreate":1637107392589,"gmtModify":1637107570780,"author":{"id":3580799596568967,"idStr":"3580799596568967","authorId":3580799596568967,"authorIdStr":"3580799596568967","name":"WifeWhyWhy","avatar":"https://static.tigerbbs.com/27b090f2d194da555f7652c92f28fc6b","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":15,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Comment</body></html>","htmlText":"<html><head></head><body>Comment</body></html>","text":"Comment","highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":18,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/871428443","repostId":1146346833,"repostType":4,"repost":{"id":"1146346833","kind":"news","pubTimestamp":1637106392,"share":"https://www.laohu8.com/m/news/1146346833?lang=zh_CN&edition=full","pubTime":"2021-11-17 07:46","market":"us","language":"en","title":"FDA promises quick review of Pfizer booster for all adults, CDC meets Friday<blockquote>FDA 承诺对所有成年人快速审查辉瑞加强剂，疾病预防控制中心周五召开会议</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1146346833","media":"Reuters","summary":"(Reuters) - The U.S. Food and Drug Administration (FDA) said on Tuesday it would review Pfizer Inc's","content":"(Reuters) - The U.S. Food and Drug Administration (FDA) said on Tuesday it would review Pfizer Inc's request to authorize booster doses of COVID-19 vaccine in all adults \"as expeditiously as possible,\" with the New York Times reporting that the regulatory nod could come as soon as Thursday.<blockquote>（路透社）-美国。美国食品药品监督管理局 (FDA) 周二表示，将“尽快”审查辉瑞公司授权所有成年人接种 COVID-19 疫苗加强剂量的请求，《纽约时报》报道称，监管机构最早可能在周四批准。</blockquote> The agency said it does not plan to hold a meeting of the outside experts on Pfizer's request, concluding the request does not raise questions that would benefit from additional discussion by the members of the committee.<blockquote>该机构表示，不打算应辉瑞公司的要求召开外部专家会议，并得出结论，该请求没有提出有利于委员会成员进一步讨论的问题。</blockquote> The decision from the FDA will likely come before a U.S. Centers for Disease Control and Prevention (CDC) advisory panel meets on Friday to discuss expanding the eligibility for booster doses of Pfizer/BioNTech's vaccine, currently allowed for select groups of people.<blockquote>FDA的决定可能会在美国疾病控制和预防中心（CDC）顾问小组周五开会讨论扩大辉瑞/BioNTech疫苗加强剂量的资格之前做出，目前允许特定人群接种。</blockquote> Earlier this month, Pfizer had requested the FDA to authorize booster doses of the vaccine in all adults, presenting recent data showing the shot would help prevent disease across ages.<blockquote>本月早些时候，辉瑞公司已要求美国食品和药物管理局授权在所有成年人中接种加强剂量的疫苗，并提供了最近的数据显示，该疫苗将有助于预防各年龄段的疾病。</blockquote> The company's third dose has been authorized for immunocompromised individuals, people aged 65 and above, all those at high risk of severe disease, and people who are regularly exposed to the virus.<blockquote>该公司的第三剂疫苗已被授权用于免疫功能低下的个人、65岁及以上的人、所有患严重疾病的高风险人群以及经常接触该病毒的人。</blockquote> U.S. President Joe Biden's administration in August announced plans to roll out booster doses for all adults in September.<blockquote>美国总统乔·拜登政府于 8 月宣布计划于 9 月为所有成年人推出加强剂量。</blockquote> The CDC sets U.S. adult and childhood immunization schedules based on recommendations from the Advisory Committee on Immunization Practices.<blockquote>疾病预防控制中心根据免疫实践咨询委员会的建议制定美国成人和儿童免疫接种计划。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA promises quick review of Pfizer booster for all adults, CDC meets Friday<blockquote>FDA 承诺对所有成年人快速审查辉瑞加强剂，疾病预防控制中心周五召开会议</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA promises quick review of Pfizer booster for all adults, CDC meets Friday<blockquote>FDA 承诺对所有成年人快速审查辉瑞加强剂，疾病预防控制中心周五召开会议</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nReuters2021-11-17 07:46\n\n</h4>\n</header>\n<article>\n(Reuters) - The U.S. Food and Drug Administration (FDA) said on Tuesday it would review Pfizer Inc's request to authorize booster doses of COVID-19 vaccine in all adults \"as expeditiously as possible,\" with the New York Times reporting that the regulatory nod could come as soon as Thursday.<blockquote>（路透社）-美国。美国食品药品监督管理局 (FDA) 周二表示，将“尽快”审查辉瑞公司授权所有成年人接种 COVID-19 疫苗加强剂量的请求，《纽约时报》报道称，监管机构最早可能在周四批准。</blockquote> The agency said it does not plan to hold a meeting of the outside experts on Pfizer's request, concluding the request does not raise questions that would benefit from additional discussion by the members of the committee.<blockquote>该机构表示，不打算应辉瑞公司的要求召开外部专家会议，并得出结论，该请求没有提出有利于委员会成员进一步讨论的问题。</blockquote> The decision from the FDA will likely come before a U.S. Centers for Disease Control and Prevention (CDC) advisory panel meets on Friday to discuss expanding the eligibility for booster doses of Pfizer/BioNTech's vaccine, currently allowed for select groups of people.<blockquote>FDA的决定可能会在美国疾病控制和预防中心（CDC）顾问小组周五开会讨论扩大辉瑞/BioNTech疫苗加强剂量的资格之前做出，目前允许特定人群接种。</blockquote> Earlier this month, Pfizer had requested the FDA to authorize booster doses of the vaccine in all adults, presenting recent data showing the shot would help prevent disease across ages.<blockquote>本月早些时候，辉瑞公司已要求美国食品和药物管理局授权在所有成年人中接种加强剂量的疫苗，并提供了最近的数据显示，该疫苗将有助于预防各年龄段的疾病。</blockquote> The company's third dose has been authorized for immunocompromised individuals, people aged 65 and above, all those at high risk of severe disease, and people who are regularly exposed to the virus.<blockquote>该公司的第三剂疫苗已被授权用于免疫功能低下的个人、65岁及以上的人、所有患严重疾病的高风险人群以及经常接触该病毒的人。</blockquote> U.S. President Joe Biden's administration in August announced plans to roll out booster doses for all adults in September.<blockquote>美国总统乔·拜登政府于 8 月宣布计划于 9 月为所有成年人推出加强剂量。</blockquote> The CDC sets U.S. adult and childhood immunization schedules based on recommendations from the Advisory Committee on Immunization Practices.<blockquote>疾病预防控制中心根据免疫实践咨询委员会的建议制定美国成人和儿童免疫接种计划。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://finance.yahoo.com/news/1-fda-promises-quick-review-233151677.html\">Reuters</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/1-fda-promises-quick-review-233151677.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146346833","content_text":"(Reuters) - The U.S. Food and Drug Administration (FDA) said on Tuesday it would review Pfizer Inc's request to authorize booster doses of COVID-19 vaccine in all adults \"as expeditiously as possible,\" with the New York Times reporting that the regulatory nod could come as soon as Thursday.\nThe agency said it does not plan to hold a meeting of the outside experts on Pfizer's request, concluding the request does not raise questions that would benefit from additional discussion by the members of the committee.\nThe decision from the FDA will likely come before a U.S. Centers for Disease Control and Prevention (CDC) advisory panel meets on Friday to discuss expanding the eligibility for booster doses of Pfizer/BioNTech's vaccine, currently allowed for select groups of people.\nEarlier this month, Pfizer had requested the FDA to authorize booster doses of the vaccine in all adults, presenting recent data showing the shot would help prevent disease across ages.\nThe company's third dose has been authorized for immunocompromised individuals, people aged 65 and above, all those at high risk of severe disease, and people who are regularly exposed to the virus.\nU.S. President Joe Biden's administration in August announced plans to roll out booster doses for all adults in September.\nThe CDC sets U.S. adult and childhood immunization schedules based on recommendations from the Advisory Committee on Immunization Practices.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":580,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/871428443"}